Single award · contract

COVID-19 Mrna Vaccines

Award ID: W58P0522C0017

FY2022 · complete year · data as of 2026-07-11

A single federal award, with both ends of the trail linked.

$1.8B
Total award value

Award W58P0522C0017 is a contract from the Department of Defense to Moderna US, Inc., $1.8B obligated, FY2022 to FY2023, for COVID-19 Mrna Vaccines. The work is performed in Massachusetts. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source

Agency ›
Department of Defense
Source
awarded→$1.8B
Recipient ›
Moderna US, Inc.
Source
performed in→
State ›
Massachusetts
Source

Award details

Award typeContract
PIIDW58P0522C0017
Action date2022
Period8 mo
Awarding agencyDepartment of Defense →
RecipientModerna US, Inc. →
Place of performanceMassachusetts →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$1,788,399,999

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
SSN 802 and 803 Long Lead Time Material
awarded 2017$35.7B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.